Saturday, July 27, 2024
- Advertisement -spot_img

TAG

potential

TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union

Cambridge, Mass., June 24, 2024 (GLOBE NEWSWIRE) --  Biogen Inc. (Nasdaq: BIIB) announced that the European Commission (EC) has granted approval for TOFIDENCETM, a...

Unveiling Europe’s corporate car problem

In the EU, six out of ten new car registrations are corporate. Because of the size...

Latest news

- Advertisement -spot_img